▲ Peaking
Business
🔮 fades
Some people are getting shut out when it comes to GLP-1 drugs. Here’s why.
Insurance coverage and supply limitations for GLP-1 drugs like Ozempic, Wegovy, and Zepbound are creating a growing divide in patient access.